Advances in pharmacotherapy for treating female sexual dysfunction

Dehydroepiandrosterone; Female sexual interest/arousal disorder; Genito-pelvic pain/penetration disorder; Hormone therapy; Local estrogen therapy; Ospemifene; Psychoactive drugs; Testosterone; Buspirone; Clinical Trials, Phase III as Topic; Estrogens; Female; Humans; Menopause; Norpregnenes; Piperazines; Purines; Selective Estrogen Receptor Modulators; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulfonamides; Tamoxifen; Testosterone; Pharmacology (medical); Pharmacology; Medicine (all)